Kamon Shirakawa

1.3k total citations
40 papers, 914 citations indexed

About

Kamon Shirakawa is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Kamon Shirakawa has authored 40 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Immunology and 7 papers in Hematology. Recurrent topics in Kamon Shirakawa's work include Cell death mechanisms and regulation (6 papers), Immune Response and Inflammation (5 papers) and Platelet Disorders and Treatments (4 papers). Kamon Shirakawa is often cited by papers focused on Cell death mechanisms and regulation (6 papers), Immune Response and Inflammation (5 papers) and Platelet Disorders and Treatments (4 papers). Kamon Shirakawa collaborates with scholars based in Japan and United States. Kamon Shirakawa's co-authors include Shoji Furusako, Norio Nakamura, Yasunori Yaegashi, Satoko Imai, Shigeatsu Endo, Yasushi Suzuki, Gaku Takahashi, Nobuhiro Sato, Masahiro Kojika and Hisataka Kobayashi and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Scientific Reports.

In The Last Decade

Kamon Shirakawa

38 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamon Shirakawa Japan 16 296 236 192 164 136 40 914
Taichin Koh Japan 17 229 0.8× 358 1.5× 266 1.4× 36 0.2× 106 0.8× 30 905
Y T Wachtfogel United States 17 131 0.4× 171 0.7× 241 1.3× 122 0.7× 251 1.8× 22 1.4k
L Armstrong United Kingdom 12 139 0.5× 154 0.7× 210 1.1× 27 0.2× 112 0.8× 17 800
Annemie J. Schuerwegh Belgium 23 121 0.4× 227 1.0× 409 2.1× 53 0.3× 113 0.8× 44 1.6k
Aharon Klar Israel 19 143 0.5× 328 1.4× 76 0.4× 55 0.3× 169 1.2× 51 993
Cheryl L. Maier United States 18 161 0.5× 305 1.3× 200 1.0× 28 0.2× 134 1.0× 77 1.1k
Mariane Tami Amano Brazil 16 114 0.4× 586 2.5× 249 1.3× 57 0.3× 185 1.4× 46 1.3k
Rafael L. Perez United States 14 214 0.7× 179 0.8× 149 0.8× 35 0.2× 136 1.0× 41 1.2k
Klaus Stahl Germany 20 251 0.8× 156 0.7× 174 0.9× 20 0.1× 202 1.5× 55 1.1k
Rafael Velázquez‐Cruz Mexico 24 205 0.7× 652 2.8× 334 1.7× 113 0.7× 90 0.7× 101 1.6k

Countries citing papers authored by Kamon Shirakawa

Since Specialization
Citations

This map shows the geographic impact of Kamon Shirakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamon Shirakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamon Shirakawa more than expected).

Fields of papers citing papers by Kamon Shirakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamon Shirakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamon Shirakawa. The network helps show where Kamon Shirakawa may publish in the future.

Co-authorship network of co-authors of Kamon Shirakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kamon Shirakawa. A scholar is included among the top collaborators of Kamon Shirakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamon Shirakawa. Kamon Shirakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Natsumeda, Manabu, Kamon Shirakawa, Masayasu Okada, et al.. (2023). Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas. Thrombosis Research. 223. 36–43. 10 indexed citations
2.
Nakamura, Masaki, Takashi Takeuchi, Kamon Shirakawa, & Shoji Furusako. (2017). Anti-human CD14 monoclonal antibody improves survival following sepsis induced by endotoxin, but not following polymicrobial infection. European Journal of Pharmacology. 806. 18–24. 9 indexed citations
3.
Hosaka, Yoshitaka, et al.. (2015). Establishment of immunoassay for platelet-derived soluble glycoprotein VI, a novel platelet marker. Journal of Immunological Methods. 418. 52–60. 2 indexed citations
4.
Hosaka, Yoshitaka, et al.. (2014). Properties of soluble glycoprotein VI, a potential platelet activation biomarker. Platelets. 26(8). 745–750. 7 indexed citations
5.
Takayama, Hiroshi, et al.. (2008). A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor γ-chain complex. Journal of Clinical Investigation. 118(5). 1785–1795. 50 indexed citations
6.
Nakamura, Masaki, et al.. (2008). Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model. Critical Care. 12(Suppl 2). P194–P194. 25 indexed citations
7.
Yaegashi, Yasunori, Nobuhiro Sato, Yasushi Suzuki, et al.. (2005). Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. Journal of Infection and Chemotherapy. 11(5). 234–238. 241 indexed citations
8.
Kurisaki, Tomohiro, et al.. (2005). Role of Meltrin α (ADAM12) in Obesity Induced by High- Fat Diet. Endocrinology. 146(4). 1752–1763. 36 indexed citations
9.
Lin, Shide, Akihiro Sato, Yasuhiro Takikawa, Kamon Shirakawa, & Kazuyuki Suzuki. (2002). Plasma and urine levels of urinary trypsin inhibitor in patients with acute and fulminant hepatitis. Journal of Gastroenterology and Hepatology. 17(2). 140–147. 18 indexed citations
10.
Oya, Takeshi, et al.. (2002). Platelet‐derived growth factor‐b expression induced after rat peripheral nerve injuries. Glia. 38(4). 303–312. 61 indexed citations
11.
Kuwano, Kazuyoshi, Takashige Maeyama, Ichiro Inoshima, et al.. (2002). Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases. Respirology. 7(1). 15–21. 43 indexed citations
12.
Kato, Yutaka, Yoshitaka Hosaka, Tomohiro Takahashi, et al.. (2001). Effect of trapidil on effector functions of monocytes related to atherosclerotic plaque. European Journal of Pharmacology. 428(3). 371–379. 5 indexed citations
13.
Kuwano, Kazuyoshi, Naoki Hagimoto, Masayuki Kawasaki, et al.. (2000). Expression of FasL and Fas Protein and Their Soluble Form in Patients with Hypersensitivity Pneumonitis. International Archives of Allergy and Immunology. 122(3). 209–215. 19 indexed citations
14.
Saitoh, Takayuki, Masamitsu Karasawa, Kamon Shirakawa, et al.. (2000). Improvement of extrathymic T cell type of large granular lymphocyte (LGL) leukemia by cyclosporin A: the serum level of Fas ligand is a marker of LGL leukemia activity. European Journal Of Haematology. 65(4). 272–275. 29 indexed citations
15.
Kuwano, Kazuyoshi, Masayuki Kawasaki, Takashige Maeyama, et al.. (2000). Soluble Form of Fas and Fas Ligand in BAL Fluid From Patients With Pulmonary Fibrosis and Bronchiolitis Obliterans Organizing Pneumonia. CHEST Journal. 118(2). 451–458. 59 indexed citations
16.
Yamaguchi, Seiji, Minako Yamaoka‐Tojo, Masaki Okuyama, et al.. (1999). Elevated circulating levels and cardiac secretion of soluble fas ligand in patients with congestive heart failure. The American Journal of Cardiology. 83(10). 1500–1503. 64 indexed citations
17.
Kanda, Yoshinobu, Shigeru Chiba, Yuji Tanaka, et al.. (1999). Increased Serum Soluble Fas Ligand Associated with Recurrent B-Cell Non-Hodgkin's Lymphoma after Autologous Peripheral Blood Stem Cell Transplantation. Leukemia & lymphoma. 34(5-6). 625–628. 10 indexed citations
18.
Saito, Mineki, Norio Nakamura, Masahiro Nagai, et al.. (1999). Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients. Journal of Neuroimmunology. 98(2). 221–226. 15 indexed citations
19.
Kato, Nobuo, Kamon Shirakawa, Hisataka Kobayashi, & Chikahiro Sakazawa. (1983). The Dismutation of Aldehydes by a Bacterial Enzyme. Agricultural and Biological Chemistry. 47(1). 39–46. 40 indexed citations
20.
Shirakawa, Kamon, et al.. (1980). [Clinical and electrophysiological studies on a case of myokymia evidence suggesting the hyperexcitability of the proximal alpha motor fibers (author's transl)].. PubMed. 20(5). 346–53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taichin Koh Breakdown of academic impact, for papers by Y T Wachtfogel Breakdown of academic impact, for papers by L Armstrong Breakdown of academic impact, for papers by Annemie J. Schuerwegh Breakdown of academic impact, for papers by Aharon Klar Breakdown of academic impact, for papers by Cheryl L. Maier Breakdown of academic impact, for papers by Mariane Tami Amano Breakdown of academic impact, for papers by Rafael L. Perez Breakdown of academic impact, for papers by Klaus Stahl Breakdown of academic impact, for papers by Rafael Velázquez‐Cruz
Rankless by CCL
2026